Baker Brothers Life Sciences Capital (GP), LLC Insider Trading $INCY INCYTE CORP
Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM).
Baker Brothers Life Sciences Capital (GP), LLC in INCYTE CORP
Trading Symbol: INCYIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 12,430,783 shares
Current Value: $1,469,069,935
Latest Transaction: Jan 17 2012
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC in INCYTE CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, IBPI, AUXL, BCRX, GHDX, HRTX, INCY, TZYM, PCYC, SGEN, GEVA, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 17 2012 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.62 | 41,677 | 692,680 | 12,430,783 | 12.4 M to 12.4 M (+0.34 %) |
Jan 17 2012 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.58 | 72,978 | 1,209,822 | 12,389,106 | 12.3 M to 12.4 M (+0.59 %) |
Jan 17 2012 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.46 | 102,856 | 1,692,732 | 12,316,128 | 12.2 M to 12.3 M (+0.84 %) |
Jan 17 2012 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.21 | 219,881 | 3,563,413 | 12,213,272 | 12 M to 12.2 M (+1.83 %) |
Jan 17 2012 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.38 | 105,847 | 1,734,060 | 11,993,391 | 11.9 M to 12 M (+0.89 %) |
Dec 12 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.26 | 178,474 | 2,366,440 | 11,887,544 | 11.7 M to 11.9 M (+1.52 %) |
Dec 12 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.19 | 2,727 | 35,969 | 11,709,070 | 11.7 M to 11.7 M (+0.02 %) |
Dec 12 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.44 | 62,395 | 838,764 | 11,706,343 | 11.6 M to 11.7 M (+0.54 %) |
Dec 12 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.47 | 159,925 | 2,153,422 | 11,643,948 | 11.5 M to 11.6 M (+1.39 %) |
Dec 07 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.22 | 68,955 | 911,895 | 11,484,023 | 11.4 M to 11.5 M (+0.60 %) |
Dec 07 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.21 | 75,948 | 1,003,319 | 11,415,068 | 11.3 M to 11.4 M (+0.67 %) |
Dec 07 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.54 | 146,090 | 1,978,409 | 11,339,120 | 11.2 M to 11.3 M (+1.31 %) |
Dec 07 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.52 | 192,316 | 2,599,651 | 11,193,030 | 11 M to 11.2 M (+1.75 %) |
Dec 07 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.88 | 48,697 | 675,715 | 11,000,714 | 11 M to 11 M (+0.44 %) |
Dec 07 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.89 | 1,023,128 | 14,207,462 | 10,952,017 | 9.9 M to 11 M (+10.30 %) |
Dec 01 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.78 | 267,768 | 3,689,843 | 9,928,889 | 9.7 M to 9.9 M (+2.77 %) |
Dec 01 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.36 | 317,429 | 4,557,709 | 9,661,121 | 9.3 M to 9.7 M (+3.40 %) |
Dec 01 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.18 | 243,425 | 3,450,817 | 9,343,692 | 9.1 M to 9.3 M (+2.67 %) |
Dec 01 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.29 | 257,911 | 3,427,972 | 9,100,267 | 8.8 M to 9.1 M (+2.92 %) |
Dec 01 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 13.60 | 250,000 | 3,398,925 | 8,842,356 | 8.6 M to 8.8 M (+2.91 %) |
Dec 01 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 12.23 | 582,677 | 7,127,713 | 8,592,356 | 8 M to 8.6 M (+7.27 %) |
Dec 01 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 12.19 | 486,969 | 5,935,324 | 8,009,679 | 7.5 M to 8 M (+6.47 %) |
Jul 05 2011 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | J | 0.00 | 11,664 | 0 | 7,522,710 | 7.5 M to 7.5 M (+0.16 %) |
Page: 1